Form 4: J&J CEO Duato's Equity Transactions Post-Vesting

Johnson & Johnson CEO Joaquin Duato reported multiple equity transactions, including vesting of restricted and performance share units and new option grants, primarily related to long-term incentive plans.

Summary

• Joaquin Duato, CEO and Chairman of the Board of Johnson & Johnson, reported several transactions involving JNJ common stock and derivative securities.
• On February 13, 2026, Duato acquired 3,469 shares from Restricted Share Units (RSUs) vesting and 73,054 shares from Performance Share Units (PSUs) vesting, both at a $0 exercise price.
• Concurrently, 989 shares (valued at $244.55 per share) and 31,679 shares (valued at $244.55 per share) were disposed of to cover tax obligations related to the RSU and PSU vesting, respectively.
• On February 15, 2026, Duato acquired an additional 3,682 shares and 4,505 shares from RSU vesting, both at a $0 exercise price.
• Shares totaling 1,602 (valued at $243.45 per share) and 1,960 (valued at $243.45 per share) were disposed of for tax withholding upon these RSU vestings.
• Duato also received new awards on February 15, 2026, including 131,734 Employee Stock Options with an exercise price of $243.45 and an expiration date of February 15, 2036, and 9,459 Restricted Share Units.
• Following these transactions, Duato directly beneficially owns 324,447 shares of Common Stock, 998 shares indirectly through a 401k, and 30,852 shares indirectly by his spouse.
• Derivative holdings include 131,734 Employee Stock Options and 17,646 Restricted Share Units (9,459 new, plus 3,682 and 4,505 from prior awards).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively as it reflects the vesting of long-term incentive awards, indicating performance achievement, and new grants that align executive interests with future company growth. The dispositions are solely for tax purposes, which is standard practice.

Positives

• Significant vesting of Restricted Share Units (RSUs) and Performance Share Units (PSUs) indicates the achievement of performance targets and continued long-term incentive alignment for the CEO.
• New awards of 131,734 Employee Stock Options and 9,459 Restricted Share Units demonstrate ongoing commitment to executive compensation tied to future company performance.
• The increase in direct beneficial ownership of common stock (after accounting for tax withholdings) reinforces management's stake in the company's success.

Negatives

• No inherently negative aspects are present in this Form 4 filing, as the dispositions were solely for tax withholding purposes related to vested equity awards, which is a standard practice.

Future Outlook

The vesting schedules for the awarded Restricted Share Units (RSUs), Performance Share Units (PSUs), and Employee Stock Options indicate a multi-year horizon for executive incentives, aligning management's interests with long-term shareholder value creation.

Industry Context

StockSavvy.ai notes that the reported transactions are typical for executive compensation structures in large, established pharmaceutical and consumer health companies like Johnson & Johnson. The use of RSUs, PSUs, and stock options is a standard practice to incentivize long-term performance and align executive interests with shareholder returns. The tax-related dispositions are also a common feature of such equity vesting events across the industry.

Related Party Transactions

• The transactions represent direct and indirect beneficial ownership changes by Joaquin Duato, CEO and Chairman of the Board, which are inherently related-party transactions as defined by SEC regulations for insider reporting.

Stakeholder Impact

• Shareholders: The vesting and new grants of equity awards align the CEO's financial interests with long-term shareholder value. The tax-related sales are a standard part of executive compensation.
• Employees: The long-term incentive plan structure, under which these awards are granted, is a common component of executive compensation and can influence broader employee incentive programs.

Next Steps

• The remaining unvested portions of the Restricted Share Units and Employee Stock Options will continue to vest in annual installments as per their respective grant terms.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation transactions, including the vesting of equity awards and new grants, with associated tax withholdings. Such events are generally expected and do not typically provide new information that would warrant a change in investment recommendation. The transactions reflect ongoing alignment of management's interests with the company's long-term performance, which is a neutral to slightly positive factor, supporting a 'hold' recommendation for existing investors.

Keywords

Johnson & Johnson, JNJ, Joaquin Duato, SEC Form 4, Insider Trading, Equity Compensation, Restricted Share Units, Performance Share Units, Stock Options, Executive Compensation, Beneficial Ownership